Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa.

[1]  D. Bernstein,et al.  Evaluation of WC3 Rotavirus Vaccine and Correlates of Protection in Healthy Infants , 1990 .

[2]  S. Plotkin,et al.  Serotype 1 reassortant of bovine rotavirus WC3, strain WI79-9, induces a polytypic antibody response in infants. , 1990, Vaccine.

[3]  S. Plotkin,et al.  Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3. , 1990, The Journal of infectious diseases.

[4]  M. Vilar,et al.  Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants , 1990, Journal of clinical microbiology.

[5]  R. Glass,et al.  Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens , 1990, Journal of clinical microbiology.

[6]  M. Vilar,et al.  Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants , 1989, Journal of clinical microbiology.

[7]  J. Fontaine,et al.  Reactogenicity and immunogenicity of rotavirus WC3 vaccine in 5-12 month old infants. , 1989, Research in Virology.

[8]  S. Plotkin,et al.  Protective Effect of WC3 Vaccine Against Rotavirus Diarrhea in Infants During a Predominantly Serotype 1 Rotavirus Season , 1988, The Journal of infectious diseases.

[9]  G. Beards,et al.  Subgroups, serotypes, and electrophoretypes of rotavirus isolated from children in Bangui, Central African Republic , 1988, Journal of clinical microbiology.

[10]  M. Georges-Courbot,et al.  Prospective longitudinal study of rotavirus infections in children from birth to two years of age in Central Africa. , 1988, Annales de l'Institut Pasteur. Virology.

[11]  F. André,et al.  LIVE ATTENUATED ORAL ROTAVIRUS VACCINE , 1987, The Lancet.

[12]  P. Byass,et al.  TRIAL OF AN ATTENUATED BOVINE ROTAVIRUS VACCINE (RIT 4237) IN GAMBIAN INFANTS , 1987, The Lancet.

[13]  H. Greenberg,et al.  Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7. , 1987, The Journal of infectious diseases.

[14]  L. Marcelis,et al.  HORSE RESERVOIR FOR BORRELIA BURGDORFERI? , 1987, The Lancet.

[15]  S. Plotkin,et al.  PROTECTION AFFORDED BY WC3 ROTAVIRUS VACCINE AGAINST NATURAL (PREDOMINANTLY SEROTYPE 1) ROTAVIRUS INFECTION IN A PLACEBO-BLINDED EFFICACY TRIAL , 1987, Pediatric Research.

[16]  G. Zissis,et al.  FAILURE OF LIVE, ATTENUATED ORAL ROTAVIRUS VACCINE , 1986, The Lancet.

[17]  G. Zissis,et al.  A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children. , 1986, The Journal of infectious diseases.

[18]  R. Chanock,et al.  Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children. , 1986, The Journal of infectious diseases.

[19]  P. Offit,et al.  Immune response of infants and children to low-passage bovine rotavirus (strain WC3). , 1986, American journal of diseases of children.

[20]  T. Flewett.  Rotavirus vaccines--achievements and prospects. , 1986, Archives of Disease in Childhood.

[21]  M. Rennels,et al.  Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants , 1986, Pediatric infectious disease.

[22]  G. Beards,et al.  Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. , 1985, The Journal of pediatrics.

[23]  G. Zissis,et al.  PROTECTION OF INFANTS AGAINST ROTAVIRUS DIARRHOEA BY RIT 4237 ATTENUATED BOVINE ROTAVIRUS STRAIN VACCINE , 1984, The Lancet.

[24]  I. Wachsmuth,et al.  Parasitic, bacterial, and viral enteric pathogens associated with diarrhea in the Central African Republic , 1984, Journal of clinical microbiology.

[25]  K S Warren,et al.  Selective primary health care: an interim strategy for disease control in developing countries. , 1979, The New England journal of medicine.

[26]  R. Chanock,et al.  Antigenic Relationships among Five Reovirus-Like (RVL) Agents by Complement Fixation (CF) and Development of New Substitute CF Antigens for the Human RVL Agent of Infantile Gastroenteritis , 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.